Camurus

Company Description

---

Camurus is a Swedish science-led biopharmaceutical company committed to developing and commercializing innovative and differentiated medicines for the treatment of severe and chronic conditions.

New drug products with best-in-class potential are conceived based on the company’s proprietary FluidCrystal® drug delivery technologies and its extensive R&D expertise. Camurus’ clinical pipeline includes products for the treatment of opioid dependence and chronic pain, rare diseases, oncology and supportive care, which are developed in-house and in collaboration with international pharmaceutical companies.

Year founded

---

1991

Headquarters

---

Ideongatan 1A, 22362 Lund – Sweden

Shares outstanding

---

55,383,447

IPO

---

Jan. 1, 2000

Stock exchange(s)

---

Nasdaq Stockholm